The changing role of glucocorticoids in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis

Kidney Int. 2022 Feb;101(2):201-204. doi: 10.1016/j.kint.2021.11.006.

¹ University/British Heart Foundation Centre of Research Excellence, Centre of Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, UK; Department of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK. Electronic address: bean.dhaun@ed.ac.uk.
² Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Hospital Campus, UK; Department of Renal Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, UK. Electronic address: s.mcadoo@imperial.ac.uk.

No abstract available

Keywords: anti-neutrophil cytoplasm antibody; glucocorticoid; vasculitis.

Publication types